Back to Journals » Cancer Management and Research » Volume 16

The Efficiency and Safety of Triple-Drug Combination of Albumin-Bound Paclitaxel, Anlotinib and PD-1/L1 Inhibitors in the 2nd or Above Line of Advanced NSCLC: A Retrospective Cohort Study

Total article views   HTML views PDF downloads Totals
603 Dovepress* 603+ 21 624
Totals 603 21 624
*Since 8 August 2024
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 2 0 2

View citations on PubMed and Google Scholar